APN - Aspen - Further announcement regarding the acquisition of the
APN
APN
APN - Aspen - Further announcement regarding the acquisition of the
pharmaceutical business of Sigma Pharmaceticals Limited ("SIGMA") by Aspen -
conditions precedent met
ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 1985/002935/06)
Share code: APN ISIN: ZAE000066692
("Aspen")
FURTHER ANNOUNCEMENT REGARDING THE ACQUISITION OF THE PHARMACEUTICAL BUSINESS OF
SIGMA PHARMACETICALS LIMITED ("SIGMA") BY ASPEN - CONDITIONS PRECEDENT MET
Aspen shareholders are referred to the announcements released on the Securities
Exchange News Service of the JSE Limited on 16 August 2010 and 23 November 2010,
respectively, wherein, Aspen announced that the Aspen Group had reached formal
agreement with Sigma to acquire the pharmaceutical business of Sigma on a debt-
free basis for a cash consideration of A$900 million (approximately ZAR 6 148
million at current exchange rates) ("the Transaction"), and that the Transaction
was subject to a number of conditions precedent.
Aspen is pleased to announce that, following approval of the transaction
received at the extraordinary General Meeting of Sigma`s Shareholders, held on
14 January 2011, all the conditions precedent to the Transaction have now been
met and the Transaction is now unconditional. The Transaction is scheduled to
complete on 31 January 2011.
Woodmead
14 January 2011
Investment Bank and Mandated Lead Arranger and
Sponsor to Aspen Debt Advisor
Investec Bank Limited The Standard Bank of South
(Registration number Africa Limited
1969/004763/06) and (Registration number
Investec Bank (Australia) 1962/000738/06)
Limited
Date: 14/01/2011 09:02:02 Produced by the JSE SENS Department.
The SENS service is an information dissemination service administered by the
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or
implicitly, represent, warrant or in any way guarantee the truth, accuracy or
completeness of the information published on SENS. The JSE, their officers,
employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature,
howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
